These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10589368)

  • 1. TNF alpha and IL-1 beta are separate targets in chronic arthritis.
    van den Berg WB; Joosten LA; van de Loo FA
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S105-14. PubMed ID: 10589368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction.
    van den Berg WB; Joosten LA; Kollias G; van De Loo FA
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I40-8. PubMed ID: 10577972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint inflammation and cartilage destruction may occur uncoupled.
    van den Berg WB
    Springer Semin Immunopathol; 1998; 20(1-2):149-64. PubMed ID: 9836374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I.
    van den Berg WB; Bresnihan B
    Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):577-97. PubMed ID: 10652641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.
    Kuiper S; Joosten LA; Bendele AM; Edwards CK; Arntz OJ; Helsen MM; Van de Loo FA; Van den Berg WB
    Cytokine; 1998 Sep; 10(9):690-702. PubMed ID: 9770330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg.
    Brennan FM
    Arthritis Res; 2001; 3(4):211-3; discussion 214-5. PubMed ID: 11438037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
    Buchan G; Barrett K; Turner M; Chantry D; Maini RN; Feldmann M
    Clin Exp Immunol; 1988 Sep; 73(3):449-55. PubMed ID: 3264773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
    Dayer JM
    J Rheumatol Suppl; 2002 Sep; 65():10-5. PubMed ID: 12236616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.
    Joosten LA; Smeets RL; Koenders MI; van den Bersselaar LA; Helsen MM; Oppers-Walgreen B; Lubberts E; Iwakura Y; van de Loo FA; van den Berg WB
    Am J Pathol; 2004 Sep; 165(3):959-67. PubMed ID: 15331419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.
    Koenders MI; Joosten LA; van den Berg WB
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii29-33. PubMed ID: 17038468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.
    Lubberts E; Joosten LA; Helsen MM; van den Berg WB
    Cytokine; 1998 May; 10(5):361-9. PubMed ID: 9619374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritis induced with cartilage-specific antibodiesis IL-4-dependent.
    Nandakumar KS; Holmdahl R
    Eur J Immunol; 2006 Jun; 36(6):1608-18. PubMed ID: 16688680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.